Pharmaceutical firms are making strides in the Australia's medical cannabis space, but supplement and nutraceutical firms will have to wait a long time before they can do the same, says an industry expert.
Network marketing company Usana reported $1.19 billion in annual revenue in its fourth quarter earnings statement. The company now derives more than 80% of its revenue from the Asia-Pacific region.
China’s State Administration for Market Regulation (SAMR) and the Ministry of Commerce summoned all 91 direct-selling firms operating in China to a meeting as part of the “100-day operation” to clean up the health food market.
Serious adverse events represented only a tiny fraction of overall reports in a detailed look at data from two major dietary supplement manufacturers, according to a recent study.
Growing dislike for Ireland’s plans to tax vitamins, minerals, probiotics and fish oils continued this week as the country’s largest retail industry body called on the Government to review the VAT hike.
New Zealand’s natural products sector is facing yet another lengthy process of workshops, surveys and consultations to secure regulations that are fit-for-purpose, after the government signalled its intention to go back to the drawing board.
Contract manufacturing and formulation specialist Virun has launched a division devoted solely to CBD formulations. An executive said this was in response to overwhelming interest in the market.
Dietary supplements and the ingredients that go into them have always had to walk a careful line. Everyone wants efficacy. But if your ingredient is too efficacious, are you treading too close to the drug line?
The European Commission (EC) has reclassified cannabidiol (CBD) as a Novel Food in a change that may mean CBD and hemp-derived food supplements cannot be legally sold within Europe.
A Dietary Supplement Caucus has officially been registered in the 116th Congress, with the goal of enhancing “Congressional attention to the role of supplements in health promotion, disease prevention, and address the regulation of the supplement industry.”
A proposed state law in Massachusetts to restrict the sale of weight loss and muscle building supplements would open the door for an unacceptable patchwork quilt of state laws on products that are already adequately regulated at the federal level, stakeholders...
The Natural Products Association is calling for a grassroots response to oppose a bill in Massachusetts that would put sports nutrition and weight management products behind the counter and mandate the posting of a comprehensive health warning.
A commitment to transparency, which was on display at the Sports Nutrition Summit this week in San Diego, is what drives NutraIngredients-USA’s coverage decisions.
The Chinese authorities have started a '100-day operation' in a bid to weed out unscrupulous industry practices prevalent in the country's health food market.
Ninety-eight per cent of the approved health food filings in China over the last 18 months went to domestic firms, a Chinese regulatory consultancy has found.
A patent infringement lawsuit making its way through the courts could have broad implications for the supplement industry, according to an attorney representing one of the parties.
Australian firm Bod Australia reported a record US$872,240 (A$1.22m) revenue for Q4 2018, due largely to portfolio expansion and new distribution agreements.
Almost 60% of complementary healthcare practitioners in Australia think recent reforms by the Therapeutic Good Administration (TGA) have had an adverse impact on the industry, according to the regulator's own stakeholder survey.
The Natural Products Association has objected to a proposal by the US Food and Drug Administration that NPA says will result in an expanded sharing of information on US firms with foreign governments. NPA said the proposal lacks transparency and runs...
A Red Bull cartoon advert has been banned for implying that the energy drink could increase focus and concentration in the workplace: claims that were not authorised on the EU Register.
The Food and Drug Administration has announced a regulatory framework for precertifying medical device software to streamline the way in which these devices are brought to market.
The industry can expect to see a boom in China's functional gummy market as the regulatory environment relaxes, according to Chinese supplement manufacturer Sirio Pharma.
Australian regulator the Therapeutic Goods Administration (TGA) is advising "extreme caution" when purchasing health supplements online, after discovering cancer-causing contaminants in a Chinese herbal cough product.
The supplement industry has an opportunity to make a powerful case about its self regulatory capabilities during the interregnum of federal regulatory authority imposed by the budget impasse.
By Stephen Daniells, Hank Schultz, and Adi Menayang
The year is new and many people are getting out their crystal balls. NutraIngredients-USA is no different, and here are five more of our Top 10 big issues that will impact the dietary supplements industry in 2019.
The federal government shutdown has thrown a wrench into the works of the Food and Drug Administration. While food safety might not have been compromised, many of the agency’s more routine assignments are on hold and it may take months to catch up.
By Stephen Daniells, Hank Schultz and Adi Menayang
The year is new and many people are getting out their crystal balls. NutraIngredients-USA is no different, and here are five of our Top 10 big issues that will impact the dietary supplements industry in 2019.
While the Farm Bill has removed industrial hemp from Schedule I of the Controlled Substances Act, the use of CBD as an ingredient has many more hurdles to overcome especially with the FDA, according to attorney Todd A. Harrison.
Puerto Rico has passed legislation that will allow supplement companies doing business there to sidestep legislation that the industry has objected to as burdensome and unnecessary.
Whatever hemp proponents have been saying about the import of the 2018 Farm Bill, it is still illegal to market CBD containing dietary supplements in interstate commerce, FDA Commissioner Dr Scott Gottlieb, MD, reiterated yesterday. Dr Gottlieb said...
A proposal by an Arizona governmental branch to regulate supplements like drugs has been successfully opposed by the American Herbal Products Association and the Natural Products Association.
By George Paraskevakos, Executive Director, International Probiotics Association (IPA)
As I celebrated three years at IPA in April, I couldn’t help but reflect on the shape the industry has taken. Going from being sparingly mentioned in the press and fast forward to today and it is almost every other week we see probiotics in the headlines....
By Steve Mister, president/CEO of the Council for Responsible Nutrition (CRN)
Unless you’ve been living in a tree, most stakeholders in the dietary supplement industry have heard of the Supplement OWL. Please pardon the pun, but “hoo” hasn’t?
Counter to the chatter aroused by a recent report, the State of New York has not ‘banned’ CBD, according to an expert on the legality of hemp products. The state did however put some boundaries around a pilot agricultural program.
Flora Research Laboratories has debuted a comprehensive testing suite that can detect potentially dangerous synthetic cannabinoids. The service will be paired with GMP audits for companies in the CBD industry.
The latest iteration of the Farm Bill, which passed both house and senate and is headed to President Trump’s desk today, dropped a provision that would have allowed SNAP recipients to use their benefits to purchase multivitamin and mineral supplements.
One player in the cannabinoid product space is seeking to differentiate itself based on its ‘compliance.’ An official at BBB Labs, based in Boulder, CO, uses this term to refer to the company’s GMP compliant manufacturing operation.
The Codex Alimentarius Committee on Nutrition are to address the demands of regulating the global trade in nutrition products by developing a prioritisation process to address the excessive workload.
The US Food and Drug Administration has warned consumers against kratom products because of heavy metal contamination. The announcement joins numerous warnings the agency has issued in recent years on the botanical.
How to appeal to consumers in an age of information-overload and scepticism
Big health food and drink companies must go small with their marketing tactics as sceptical consumers are shunning established firms and demanding ultra-ethical brands, according to new research revealed at Health Ingredients Europe.
An extensive history with cannabis products was the foundation for a new line of CBD-free dietary supplements that target the endocannabinoid system, according to the brand’s leader.
The Food and Drug Administration has issued a consumer warning over a line of male sexual enhancement products, citing a number of severe adverse health events suffered by consumers. The alleged marketer of the products has been arraigned on federal charges.
The sports nutrition category has undergone significant change in recent years, as many new non-core consumers are seeking out the products. This has coincided with increased regulatory scrutiny and calls for greater transparency, says the COO of ProSupps.
The kratom market has suffered another black eye with the release of a warning letter from FDA citing a marketer for material that was contaminated with salmonella. The letter also illustrates the ongoing regulatory ferment surrounding the botanical.
The prevalence of Bacillus cereus in infant and follow-up formula in China may warrant further research so criteria can be developed for risk assessment and quality control, say Chinese researchers.
China will not implement a new set of cross-border e-commerce (CBEC) regulations in January next year and will instead continue with existing regulations.
The US Food and Drug Administration (FDA) sent warning letters to two companies selling products marketed as ‘dietary supplements’ and labeled as containing tianeptine, which is being illegally claimed to treat opioid use disorder (OUD), pain, and anxiety.